These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6886045)

  • 1. Endocrine correlates of mood response to methylphenidate in depression.
    Roy-Byrne PP; Gwirtsman HE; Baxter L; Gerner RH
    J Clin Psychopharmacol; 1983 Aug; 3(4):266-8. PubMed ID: 6886045
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive methylphenidate response and blunted thyrotropin-releasing hormone response in depression.
    Schwarcz G; Halaris A; Gwirtsman H; Ahles S
    Am J Psychiatry; 1986 Mar; 143(3):397. PubMed ID: 3082222
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroendocrinologic and endocrinologic research in depressive patients].
    Holsboer F; Benkert O
    Nervenarzt; 1985 Jan; 56(1):1-11. PubMed ID: 2858062
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate in treating poststroke depression.
    Lingam VR; Lazarus LW; Groves L; Oh SH
    J Clin Psychiatry; 1988 Apr; 49(4):151-3. PubMed ID: 3356672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Sahoo M; Subho C
    Psychoneuroendocrinology; 2007 Feb; 32(2):210; author reply 211-2. PubMed ID: 17198745
    [No Abstract]   [Full Text] [Related]  

  • 6. Monthly variations of serum levels of thyrotropin, growth hormone and cortisol in man.
    Golstein J; Van Cauter E; Leclercq R; Copinschi G; Vanhaelst L
    Horm Metab Res; 1974 Nov; 6(6):506-9. PubMed ID: 4452549
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 10. Should psychostimulants be used to treat delirious patients with depressed mood?
    Levenson JA
    J Clin Psychiatry; 1992 Feb; 53(2):69. PubMed ID: 1541609
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylphenidate for depression.
    Huessy HR
    Am J Psychiatry; 1983 Sep; 140(9):1272-3. PubMed ID: 6614261
    [No Abstract]   [Full Text] [Related]  

  • 12. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Duval F; Mokrani MC; Monreal-Ortiz JA; Fattah S; Champeval C; Schulz P; Macher JP
    Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate and psychotic depression.
    Ng BK
    Clin Neuropharmacol; 2009; 32(3):177. PubMed ID: 19483495
    [No Abstract]   [Full Text] [Related]  

  • 14. Elderly depressed females as a possible subgroup of patients responsive to methylphenidate.
    Askinazi C; Weintraub RJ; Karamouz N
    J Clin Psychiatry; 1986 Sep; 47(9):467-9. PubMed ID: 3745129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

  • 16. d-Amphetamine versus methylphenidate effects in depressed inpatients.
    Little KY
    J Clin Psychiatry; 1993 Sep; 54(9):349-55. PubMed ID: 8407854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary phenylacetate and response to methylphenidate.
    Baxter LR; Kelly RC; Peter JB; Liston EH; Touserkani S
    J Psychiatr Res; 1988; 22(2):131-9. PubMed ID: 3404481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of growth hormone releasing hormone (GHRH) on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression].
    Frieboes RM; Schier T; Guldner J; Colla-Müller M; Murck H; Steiger A
    Wien Med Wochenschr; 1995; 145(17-18):499-500. PubMed ID: 8588384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of methylphenidate in depressed patients after cardiac surgery.
    Kaufmann MW; Cassem N; Murray G; MacDonald D
    J Clin Psychiatry; 1984 Feb; 45(2):82-4. PubMed ID: 6693366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood response to methylphenidate in depressed patients on zimelidine.
    Joyce PR
    J Clin Psychopharmacol; 1986 Oct; 6(5):317-8. PubMed ID: 2945837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.